Format

Send to

Choose Destination
Pediatr Blood Cancer. 2019 Nov 13:e28048. doi: 10.1002/pbc.28048. [Epub ahead of print]

Partial response to carboplatin, etoposide phosphate, and atezolizumab in a pediatric patient with high-grade metastatic tumor with rhabdoid and focal neuroendocrine features.

Author information

1
Division of Pediatric Hematology/Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
2
Division of General Surgery, Louisiana State University, Baton Rouge, Louisiana.
3
Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.
4
Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama.
5
Divisions of Hematology/Oncology & Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, Birmingham, Alabama.
6
Department of Pathology and Laboratory Medicine, Children's of Alabama, Birmingham, Alabama.
7
Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
8
Division of Anatomic Pathology, UPMC Children's Hospital, Pittsburgh, Pennsylvania.
9
Department of Pediatric Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
PMID:
31724272
DOI:
10.1002/pbc.28048

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center